BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33540282)

  • 1. Generation of the human induced pluripotent stem cell lines (CMCi009-A) from a patient with Birt-Hogg-Dubé syndrome (BHD) with heterozygous frameshift deletion mutation c.1285delC of the FLCN gene.
    Ko EJ; Cui S; Shin YJ; Lim SW; Lee KI; Lee JY; Yang CW; Kim M; Chung BH
    Stem Cell Res; 2021 Mar; 51():102215. PubMed ID: 33540282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Birt-Hogg-Dubé syndrome: novel FLCN frameshift deletion in daughter and father with renal cell carcinomas.
    Näf E; Laubscher D; Hopfer H; Streit M; Matyas G
    Fam Cancer; 2016 Jan; 15(1):127-32. PubMed ID: 26342594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splice-site mutation causing partial retention of intron in the FLCN gene in Birt-Hogg-Dubé syndrome: a case report.
    Furuya M; Kobayashi H; Baba M; Ito T; Tanaka R; Nakatani Y
    BMC Med Genomics; 2018 May; 11(1):42. PubMed ID: 29720200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and characterization of BHD-F59RSVT, an immortalized cell line derived from a renal cell carcinoma in a patient with Birt-Hogg-Dubé syndrome.
    Furuya M; Hasumi H; Baba M; Tanaka R; Iribe Y; Onishi T; Nagashima Y; Nakatani Y; Isono Y; Yao M
    Lab Invest; 2017 Mar; 97(3):343-351. PubMed ID: 27991910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel germline mutations in FLCN gene identified in two Chinese patients with Birt-Hogg-Dubé syndrome.
    Li T; Ning X; He Q; Gong K
    Chin J Cancer; 2017 Jan; 36(1):4. PubMed ID: 28069055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
    Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and genetic characteristics of chinese patients with Birt-Hogg-Dubé syndrome.
    Liu Y; Xu Z; Feng R; Zhan Y; Wang J; Li G; Li X; Zhang W; Hu X; Tian X; Xu KF; Zhang X
    Orphanet J Rare Dis; 2017 May; 12(1):104. PubMed ID: 28558743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Birt-Hogg-Dube Syndrome with a Novel Mutation in the FLCN Gene.
    Kayhan G; Yılmaz Demirci N; Turktas H; Ergun MA
    Genet Test Mol Biomarkers; 2017 Oct; 21(10):632-634. PubMed ID: 28805452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Case of Birt-Hogg-Dubé (BHD) Syndrome Harboring a Novel Folliculin (FLCN) Gene Mutation.
    Yukawa T; Fukazawa T; Yoshida M; Morita I; Kato K; Monobe Y; Furuya M; Naomoto Y
    Am J Case Rep; 2016 Oct; 17():788-792. PubMed ID: 27780965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic, epidemiologic and clinicopathologic studies of Japanese Asian patients with Birt-Hogg-Dubé syndrome.
    Furuya M; Yao M; Tanaka R; Nagashima Y; Kuroda N; Hasumi H; Baba M; Matsushima J; Nomura F; Nakatani Y
    Clin Genet; 2016 Nov; 90(5):403-412. PubMed ID: 27220747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birt-Hogg-Dubé syndrome: a literature review and case study of a Chinese woman presenting a novel FLCN mutation.
    Hao S; Long F; Sun F; Liu T; Li D; Jiang S
    BMC Pulm Med; 2017 Feb; 17(1):43. PubMed ID: 28222720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Birt-Hogg-Dubé syndrome: from gene discovery to molecularly targeted therapies.
    Schmidt LS
    Fam Cancer; 2013 Sep; 12(3):357-64. PubMed ID: 23108783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique mutation, accelerated mTOR signaling and angiogenesis in the pulmonary cysts of Birt-Hogg-Dubé syndrome.
    Nishii T; Tanabe M; Tanaka R; Matsuzawa T; Okudela K; Nozawa A; Nakatani Y; Furuya M
    Pathol Int; 2013 Jan; 63(1):45-55. PubMed ID: 23356225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
    Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
    Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign clear cell "sugar" tumor of the lung in a patient with Birt-Hogg-Dubé syndrome: a case report.
    Gunji-Niitsu Y; Kumasaka T; Kitamura S; Hoshika Y; Hayashi T; Tokuda H; Morita R; Kobayashi E; Mitani K; Kikkawa M; Takahashi K; Seyama K
    BMC Med Genet; 2016 Nov; 17(1):85. PubMed ID: 27871249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoplasmacytic lymphoma in a patient with Birt-Hogg-Dubé syndrome.
    Kurata K; Matsumoto H; Jimbo N; Yakushijin K; Yamamoto K; Ito M; Nakamachi Y; Matsuoka H; Saegusa J; Seyama K; Itoh T; Minami H
    Int J Hematol; 2020 Dec; 112(6):864-870. PubMed ID: 32789566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
    Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
    Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of
    Liu L; Yang K; Wang X; Shi Z; Yang Y; Yuan Y; Guo T; Xiao X; Luo H
    Biomed Res Int; 2017; 2017():8751384. PubMed ID: 28785590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial pleural covering for intractable pneumothorax in patients with Birt-Hogg-Dubé Syndrome.
    Okada A; Hirono T; Watanabe T; Hasegawa G; Tanaka R; Furuya M
    Clin Respir J; 2017 Mar; 11(2):224-229. PubMed ID: 26073198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology of Birt-Hogg-Dubé syndrome: A special reference of pulmonary manifestations in a Japanese population with a comprehensive analysis and review.
    Furuya M; Nakatani Y
    Pathol Int; 2019 Jan; 69(1):1-12. PubMed ID: 30632664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.